Technologieangebote

Neue Therapie für Schlaganfall

The novel combination therapy, developed at the Julius-Maximilians-Universität Würzburg, is based on a combined treatment strategy using glucocorticoids combined with inhibitors of the proteasome . The new therapy effectively and significantly reduced edema formation and moreover significantly ameliorated neurological performance in mouse models of stroke and brain trauma.

Weitere Informationen: PDF

Bayerische Patentallianz GmbH
Tel.: +49 89 5480177-0

Ansprechpartner
Peer Biskup

Kommentare (0)

Schreiben Sie einen Kommentar